• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The regulation of biobanks in Spain.

作者信息

Nys Herman, Fobelets Geraldine

机构信息

Centre of Biomedical Ethics and Law, Catholic University of Leuven, Leuven, Belgium.

出版信息

Rev Derecho Genoma Hum. 2008 Jul-Dec(29):169-88.

PMID:19334411
Abstract

On 3 July 2007 the Spanish parliament approved the Biomedical Research Act. This article discusses the provisions of the Biomedical Research Act that are directly relevant for the regulatory framework of biobanks in Spain. This means that we are not only interested in the procedural and administrative dispositions governing biobanks. Our main preoccupation relates to the substantial provisions governing the collection, the research use and the conservation of biological samples. Our contribution starts in the second part with a brief description of the definition of "biobank" in the Spanish Act. Subsequently, in the third part, we deal extensively with the legal conditions for the collection, use and conservation of biological samples and accompanying data for biomedical research purposes. In the fourth part we examine the specific legal framework of research biobanks in Spain, with a special focus on the source's right to know or not to know, his right to privacy and his right to non-discrimination. A discussion of the main characteristics of the Act and some conclusions finalise this article. In stead of summarising these conclusions in our own words, we prefer to cite the legislator who stated in the preamble to the Act the following: "The regulation on the obtaining, conservation, use and assignment of biological samples is likewise object of a detailed regulation. As is logical, the legal framework turns once again on the consent of the source of the samples and on the previous information that must be provided to this respect. In so far as the disjunctive on the possibility to grant a completely generic or a specific consent on the use or latter uses of the sample, the Law has chosen an intermediate and flexible regulation, in that the initial consent may provide coverage, if in the information previously provided to the subject source there has been a provision about later researches related with the initial, including the researches that may be undertaken by third parties and the assignment of the data or of identified or identifiable samples to them".

摘要

相似文献

1
The regulation of biobanks in Spain.
Rev Derecho Genoma Hum. 2008 Jul-Dec(29):169-88.
2
Alternative consent models for biobanks: the new Spanish law on biomedical research.生物样本库的替代同意模式:西班牙关于生物医学研究的新法律
Bioethics. 2008 Sep;22(8):440-7. doi: 10.1111/j.1467-8519.2008.00673.x. Epub 2008 Jul 17.
3
[Consent, biobanks and biomedical research law].[同意、生物样本库与生物医学研究法]
Rev Derecho Genoma Hum. 2008 Jul-Dec(29):131-48.
4
[Biobanks and use of samples of human origin for surgical research. Current regulatory framework].[生物样本库与人类源样本在外科研究中的应用。现行监管框架]
Cir Esp. 2011 Apr;89(4):207-12. doi: 10.1016/j.ciresp.2010.07.014. Epub 2011 Jan 21.
5
Spanish Regulation of Biobanks.西班牙生物样本库的监管
J Law Med Ethics. 2015 Winter;43(4):801-15. doi: 10.1111/jlme.12321.
6
Taiwan Regulation of Biobanks.台湾生物样本库的管理规定
J Law Med Ethics. 2015 Winter;43(4):816-26. doi: 10.1111/jlme.12322.
7
Biobanks and their importance in the clinical and scientific fields related to Spanish biomedical research.生物样本库及其在与西班牙生物医学研究相关的临床和科学领域中的重要性。
Reumatol Clin. 2014 Sep-Oct;10(5):304-8. doi: 10.1016/j.reuma.2014.02.011. Epub 2014 May 28.
8
[Biobanks: in the interests of researchers or donors?].[生物样本库:符合研究人员还是捐赠者的利益?]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016 Mar;59(3):304-10. doi: 10.1007/s00103-015-2291-6.
9
Legacy samples in Finnish biobanks: social and legal issues related to the transfer of old sample collections into biobanks.芬兰生物银行中的遗留样本:与将旧样本集转移到生物银行相关的社会和法律问题。
Hum Genet. 2019 Dec;138(11-12):1287-1299. doi: 10.1007/s00439-019-02070-0. Epub 2019 Oct 16.
10
Legal issues surrounding French research-focused biobanks.围绕法国以研究为重点的生物样本库的法律问题。
J Int Bioethique. 2009 Sep;20(3):69-86, 149. doi: 10.3917/jib.203.0069.

引用本文的文献

1
Ethical aspects of human biobanks: a systematic review.人类生物样本库的伦理问题:一项系统综述。
Croat Med J. 2011 Jun;52(3):262-79. doi: 10.3325/cmj.2011.52.262.
2
Legal and ethical consequences of international biobanking from a national perspective: the German BMB-EUCoop project.从国家角度看国际生物银行的法律和伦理后果:德国 BMB-EUCoop 项目。
Eur J Hum Genet. 2010 May;18(5):522-5. doi: 10.1038/ejhg.2009.214. Epub 2009 Dec 2.